Lung Microbiome as a Treatable Trait in Chronic Respiratory Disorders-Reference-Cited by-同舟云学术

Lung Microbiome as a Treatable Trait in Chronic Respiratory Disorders

Published:2023-09-26 Issue:5 Volume:201 Page:455-466
ISSN:0341-2040
Container-title:Lung
language:en
Short-container-title:Lung

Author:

Scialò Filippo,Vitale Maria,D’Agnano Vito,Mariniello Domenica Francesca,Perrotta Fabio,Castaldo Alice,Campbell Susan F. M.,Pastore Lucio,Cazzola Mario,Bianco Andrea

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00408-023-00645-3.pdf

Reference115 articles.

1. Zitvogel L, Daillère R, Roberti MP, Routy B, Kroemer G (2017) Anticancer effects of the microbiome and its products. Nat Rev Microbiol 15(8):465–478

2. Huffnagle GB, Dickson RP, Lukacs NW (2017) The respiratory tract microbiome and lung inflammation: a two-way street. Mucosal Immunol 10(2):299–306

3. Yagi K, Huffnagle GB, Lukacs NW, Asai N (2021) The lung microbiome during health and disease. Int J Mol Sci 22(19):1–13

4. Chotirmall SH, Gellatly SL, Budden KF, Mac Aogain M, Shukla SD, Wood DLA et al (2017) Microbiomes in respiratory health and disease: an Asia-Pacific perspective. Respirology 22(2):240–250

5. Budden KF, Shukla SD, Rehman SF, Bowerman KL, Keely S, Hugenholtz P et al (2019) Functional effects of the microbiota in chronic respiratory disease. Lancet Respir Med 7(10):907–920

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of airways microbiota on local and systemic diseases: a rationale for probiotics delivery to the respiratory tract;Expert Opinion on Drug Delivery;2024-07-02

2. Tyndallized bacteria prime bronchial epithelial cells to mount an effective innate immune response against infections;Human Cell;2024-05-30

3. LUNG Year in Review: 2023;Lung;2024-02

4. Multi-omics in Study of Lung Microbiome;Multi-Omics Analysis of the Human Microbiome;2024